Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 266

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 266
---
 has provided the Purchaser with a copy of the acquisition or similar agreement relating to such Acquisition Proposal, including all supporting materials, including any financing documents supplied to the Company in 
 connection therewith and a written notice from the Board regarding the value in financial terms that the Board has, in consultation with an independent financial advisor, determined should be ascribed to any                         
 non-cash consideration offered under the Superior Proposal;                                                                                                                                                                             |

| (v) | at least five (5) Business Days have elapsed since the later of the date on which the Purchaser received a                                                                                                                     
 copy of the Superior Proposal Notice and the date on which the Purchaser received all the material specified in Section 6.2(b)(iv)(B) (such five Business Day period, the “Right to Match Period”) and, for greater certainty, 
 the Right to Match Period shall expire at 11:59 p.m. (Montréal time) on the last Business Day of the Right to Match Period;                                                                                                    |

| (vi) | if the Purchaser and Parent have offered to amend the terms of the Arrangement and this Agreement during the                                                                                                                                        
 Right to Match Period pursuant to Section 6.2(c), the Board of Directors has determined, in good faith, after consultation with its outside legal counsel and financial advisors, that such Acquisition Proposal continues to constitute a Superior 
 Proposal when assessed against the Arrangement and this Agreement as it is proposed to be amended as at the termination of the Right to Match Period; and                                                                                           |

| (vii) | the Company terminates this Agreement pursuant to Section 8.2(a)(ii)(A) and concurrently pays the 
 Termination Payment pursuant to Section 8.3(a)(iii).                                              |

| (c) | During the Right to Match Period or such longer period as the Company may approve in writing for such purpose,                                                                                                                                            
 the Purchaser and Parent will have the opportunity, but not the obligation, to offer to amend the terms of the Arrangement and this Agreement. The Company agrees that, if requested by the Purchaser, it will negotiate with the Purchaser in good faith 
 to amend the terms of the Arrangement and this Agreement as would enable them to proceed with the Arrangement and any Contemplated Transactions on such adjusted terms. The Board of Directors will review any such offer by the Purchaser and Parent to  
 amend the terms of the Arrangement and this Agreement in order to determine, in good faith, whether the Purchaser and Parent’s offer to amend the